In this brief video, Womble Bond Dickinson IP litigation attorneys Ben Bourke, Mike O’Shaughnessy and Jeff Whittle discuss how life science companies can boost nascent technologies (like the mRNA tech used to make the Moderna & Pfizer vaccines) through expanding IP access to others.